Home HIV FAQ My Amedeo About Flying Publisher   

Amedeo Prize 2008
The 21 Finalists


  Malignant Lymphoma

  Free Subscription


Articles published in Cancer

Retrieve available abstracts of 60 articles:
HTML format



Single Articles


    March 2008
  1. COLEMAN M , Martin P, Ruan J, Furman R, et al
    Prednisone, etoposide, procarbazine, and cyclophosphamide (PEP-C) oral combination chemotherapy regimen for recurring/refractory lymphoma: Low-dose metronomic, multidrug therapy.
    Cancer. 2008;.
    PubMed     Related articles    Abstract available


  2. KIEWE P , Fischer L, Martus P, Thiel E, et al
    Primary central nervous system lymphoma: monocenter, long-term, intent-to-treat analysis.
    Cancer. 2008;.
    PubMed     Related articles    Abstract available


    February 2008
  3. JONES JA , Qazilbash MH, Shih YC, Cantor SB, et al
    In-hospital complications of autologous hematopoietic stem cell transplantation for lymphoid malignancies : clinical and economic outcomes from the nationwide inpatient sample.
    Cancer. 2008;112:1096-1105.
    PubMed     Related articles    Abstract available


  4. BUSSE A , Kraus M, Na IK, Rietz A, et al
    Sensitivity of tumor cells to proteasome inhibitors is associated with expression levels and composition of proteasome subunits.
    Cancer. 2008;112:659-70.
    PubMed     Related articles    Abstract available


  5. COTTA CV , Leventaki V, Atsaves V, Vidaki A, et al
    The helix-loop-helix protein Id2 is expressed differentially and induced by myc in T-cell lymphomas.
    Cancer. 2008;112:552-61.
    PubMed     Related articles    Abstract available


    January 2008
  6. HAINSWORTH JD , Vazquez ER, Spigel DR, Raefsky E, et al
    Combination therapy with fludarabine and rituximab followed by alemtuzumab in the first-line treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma: a phase 2 trial of the Minnie Pearl Cancer Research Network.
    Cancer. 2008;.
    PubMed     Related articles    Abstract available


  7. ZINZANI PL , Tani M, Fanti S, Stefoni V, et al
    A phase 2 trial of fludarabine and mitoxantrone chemotherapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma.
    Cancer. 2008;.
    PubMed     Related articles    Abstract available


    December 2007
  8. OKI Y , Pro B, Fayad LE, Romaguera J, et al
    Phase 2 study of gemcitabine in combination with rituximab in patients with recurrent or refractory Hodgkin lymphoma.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available


  9. SENECAL D , Jais JP, Desablens B, Berthou C, et al
    Twenty-year disease and treatment-associated mortality rates of patients with Hodgkin lymphoma of clinical stages IIIB and IV prospectively treated with 3-month anthracycline-based chemotherapy followed by extended high-dose radiation.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available


    November 2007
  10. LEVY O , Deangelis LM, Filippa DA, Panageas KS, et al
    Bcl-6 predicts improved prognosis in primary central nervous system lymphoma.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available


    October 2007
  11. HODGSON DC , Koh ES, Tran TH, Heydarian M, et al
    Individualized estimates of second cancer risks after contemporary radiation therapy for Hodgkin lymphoma.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available


  12. RAPKIEWICZ A , Wen H, Sen F, Das K, et al
    Cytomorphologic examination of anaplastic large cell lymphoma by fine-needle aspiration cytology.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available


  13. IWAMOTO FM , Schwartz J, Pandit-Taskar N, Peak S, et al
    Study of radiolabeled indium-111 and yttrium-90 ibritumomab tiuxetan in primary central nervous system lymphoma.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available


    September 2007
  14. KEM R , Chu KC
    Cambodian cancer incidence rates in California and Washington, 1998-2002.
    Cancer. 2007;110:1370-5.
    PubMed     Related articles    Abstract available


  15. BADROS A , Goloubeva O, Dalal JS, Can I, et al
    Neurotoxicity of bortezomib therapy in multiple myeloma: a single-center experience and review of the literature.
    Cancer. 2007;110:1042-9.
    PubMed     Related articles    Abstract available


    August 2007
  16. HALDORSEN IS , Krossnes BK, Aarseth JH, Scheie D, et al
    Increasing incidence and continued dismal outcome of primary central nervous system lymphoma in norway 1989-2003 : time trends in a 15-year national survey.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available


  17. HUANG SY , Yao M, Tang JL, Lee WC, et al
    Epidemiology of multiple myeloma in Taiwan: increasing incidence for the past 25 years and higher prevalence of extramedullary myeloma in patients younger than 55 years.
    Cancer. 2007;110:896-905.
    PubMed     Related articles    Abstract available


  18. PALUMBO A , Bringhen S, Falco P, Cavallo F, et al
    Time to first disease progression, but not beta2-microglobulin, predicts outcome in myeloma patients who receive thalidomide as salvage therapy.
    Cancer. 2007;110:824-9.
    PubMed     Related articles    Abstract available


  19. JACOBS SR , Small BJ, Booth-Jones M, Jacobsen PB, et al
    Changes in cognitive functioning in the year after hematopoietic stem cell transplantation.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available


    July 2007
  20. PANAGEAS KS , Elkin EB, Ben-Porat L, Deangelis LM, et al
    Patterns of treatment in older adults with primary central nervous system lymphoma.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available


  21. FILMONT JE , Gisselbrecht C, Cuenca X, Deville L, et al
    The impact of pre- and post-transplantation positron emission tomography using 18-fluorodeoxyglucose on poor-prognosis lymphoma patients undergoing autologous stem cell transplantation.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available


  22. WOODS G , Miceli MH, Grazziutti ML, Zhao W, et al
    Serum Aspergillus galactomannan antigen values strongly correlate with outcome of invasive aspergillosis: a study of 56 patients with hematologic cancer.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available


  23. BRITTO L , Spector N, Scheliga A
    Predictive and discriminating three-risk-group prognostic scoring system for staging Hodgkin lymphomas.
    Cancer. 2007;110:228-9.
    PubMed     Related articles   


    June 2007
  24. HUSAIN A , Roberts D, Pro B, McLaughlin P, et al
    Meta-analyses of the association between Chlamydia psittaci and ocular adnexal lymphoma and the response of ocular adnexal lymphoma to antibiotics.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available


  25. TSUKAMOTO N , Kojima M, Hasegawa M, Oriuchi N, et al
    The usefulness of (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG-PET) and a comparison of (18)F-FDG-pet with (67)gallium scintigraphy in the evaluation of lymphoma: relation to histologic subtypes based on the World Health Organization
    Cancer. 2007;.
    PubMed     Related articles    Abstract available


  26. LASKAR S , Bahl G, Muckaden MA, Nair R, et al
    Primary diffuse large B-cell lymphoma of the tonsil: is a higher radiotherapy dose required?
    Cancer. 2007;.
    PubMed     Related articles    Abstract available


  27. BRIMO F , Michel RP, Khetani K, Auger M, et al
    Primary effusion lymphoma: a series of 4 cases and review of the literature with emphasis on cytomorphologic and immunocytochemical differential diagnosis.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available


  28. CORSO A , Mangiacavalli S, Barbarano L, Alessandrino EP, et al
    Limited feasibility of double transplant in multiple myeloma: results of a multicenter study on 153 patients aged <65 years.
    Cancer. 2007;109:2273-8.
    PubMed     Related articles    Abstract available


  29. POLEY JW , Wagner A, Hoogmans MM, Menko FH, et al
    Biallelic germline mutations of mismatch-repair genes: a possible cause for multiple pediatric malignancies.
    Cancer. 2007;109:2349-56.
    PubMed     Related articles    Abstract available


    May 2007
  30. GANJOO K , Advani R, Mariappan MR, McMillan A, et al
    Non-Hodgkin lymphoma of the breast.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available


  31. MAUZ-KORHOLZ C , Gorde-Grosjean S, Hasenclever D, Shankar A, et al
    Resection alone in 58 children with limited stage, lymphocyte-predominant Hodgkin lymphoma-experience from the European network group on pediatric Hodgkin lymphoma.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available


  32. STELOW EB , Hong SM, Covell JL, Moskaluk CA, et al
    The feasibility of gene expression profiling generated in fine-needle aspiration specimens from patients with follicular lymphoma and diffuse large B-cell lymphoma.
    Cancer. 2007;.
    PubMed     Related articles   


  33. SACCHI S , Pozzi S, Marcheselli R, Federico M, et al
    Rituximab in combination with fludarabine and cyclophosphamide in the treatment of patients with recurrent follicular lymphoma.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available


  34. JABBOUR E , Hosing C, Ayers G, Nunez R, et al
    Pretransplant positive positron emission tomography/gallium scans predict poor outcome in patients with recurrent/refractory Hodgkin lymphoma.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available


  35. FERRER A , Salaverria I, Bosch F, Villamor N, et al
    Leukemic involvement is a common feature in mantle cell lymphoma.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available


  36. CANNELLA S , Santoro A, Bruno G, Pillon M, et al
    Germline mutations of the perforin gene are a frequent occurrence in childhood anaplastic large cell lymphoma.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available


    April 2007
  37. BASER S , Onn A, Lin E, Morice RC, et al
    Pulmonary manifestations in patients with cutaneous T-cell lymphomas.
    Cancer. 2007;109:1550-5.
    PubMed     Related articles    Abstract available


  38. HORGER M , Kanz L, Denecke B, Vonthein R, et al
    The benefit of using whole-body, low-dose, nonenhanced, multidetector computed tomography for follow-up and therapy response monitoring in patients with multiple myeloma.
    Cancer. 2007;109:1617-26.
    PubMed     Related articles    Abstract available


    March 2007
  39. SACCHI S , Pozzi S, Marcheselli L, Bari A, et al
    Introduction of rituximab in front-line and salvage therapies has improved outcome of advanced-stage follicular lymphoma patients.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available


  40. WITZIG TE , Molina A, Gordon LI, Emmanouilides C, et al
    Long-term responses in patients with recurring or refractory B-cell non-Hodgkin lymphoma treated with yttrium 90 ibritumomab tiuxetan.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available


  41. STRAUS DJ , Duvic M, Kuzel T, Horwitz S, et al
    Results of a Phase II trial of oral bexarotene (Targretin) combined with interferon alfa-2b (Intron-A) for patients with cutaneous T-cell lymphoma.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available


  42. MOLS F , Aaronson NK, Vingerhoets AJ, Coebergh JW, et al
    Quality of life among long-term non-Hodgkin lymphoma survivors: a population-based study.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available


    February 2007
  43. WANG F , Xu RH, Han B, Shi YX, et al
    High incidence of hepatitis B virus infection in B-cell subtype non-Hodgkin lymphoma compared with other cancers.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available


  44. TETA MJ , Lau E, Sceurman BK, Wagner ME, et al
    Therapeutic radiation for lymphoma: risk of malignant mesothelioma.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available


  45. TOMITA N , Motomura S, Hyo R, Takasaki H, et al
    Comparison of peripheral T-cell lymphomas and diffuse large B-cell lymphoma.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available


  46. FORTIN D , Gendron C, Boudrias M, Garant MP, et al
    Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in the treatment of cerebral metastasis.
    Cancer. 2007;109:751-60.
    PubMed     Related articles    Abstract available


    January 2007
  47. MAUCORT-BOULCH D , Djeridane M, Roy P, Riche B, et al
    Predictive and discriminating three-risk-group prognostic scoring system for staging Hodgkin lymphomas.
    Cancer. 2007;109:256-64.
    PubMed     Related articles    Abstract available


    November 2006
  48. OKI Y , McLaughlin P, Fayad LE, Pro B, et al
    Experience with heat shock protein-peptide complex 96 vaccine therapy in patients with indolent non-Hodgkin lymphoma.
    Cancer. 2006;.
    PubMed     Related articles    Abstract available


  49. BLUM KA , Johnson JL, Niedzwiecki D, Piro LD, et al
    Prolonged follow-up after initial therapy with 2-chlorodeoxyadenosine in patients with indolent non-Hodgkin lymphoma: results of Cancer and Leukemia Group B Study 9153.
    Cancer. 2006;.
    PubMed     Related articles    Abstract available


  50. VIGNOT S , Mounier N, Larghero J, Brice P, et al
    High-dose therapy and autologous stem-cell transplantation can improve event-free survival for indolent lymphoma : a study using patients as their own controls.
    Cancer. 2006;.
    PubMed     Related articles    Abstract available


  51. MICALLEF IN , Kahl BS, Maurer MJ, Dogan A, et al
    A pilot study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated, diffuse large B-cell lymphoma.
    Cancer. 2006;.
    PubMed     Related articles    Abstract available


  52. NAKAMURA S , Matsumoto T, Ye H, Nakamura S, et al
    Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma: a clinicopathologic and molecular study with reference to antibiotic treatment.
    Cancer. 2006;.
    PubMed     Related articles    Abstract available


    October 2006
  53. BRANDAO GD , Rose R, McKenzie S, Maslak P, et al
    Grading follicular lymphomas in fine-needle aspiration biopsies: the role of ThinPrep slides and flow cytometry.
    Cancer. 2006;108:319-23.
    PubMed     Related articles    Abstract available


  54. KOSTAKOGLU L , Goldsmith SJ, Leonard JP, Christos P, et al
    FDG-PET after 1 cycle of therapy predicts outcome in diffuse large cell lymphoma and classic Hodgkin disease.
    Cancer. 2006;.
    PubMed     Related articles    Abstract available


  55. DEMIERRE MF , Gan S, Jones J, Miller DR, et al
    Significant impact of cutaneous T-cell lymphoma on patients' quality of life: results of a 2005 National Cutaneous Lymphoma Foundation Survey.
    Cancer. 2006;.
    PubMed     Related articles    Abstract available


  56. AKYUREK N , Ren Y, Rassidakis GZ, Schlette EJ, et al
    Expression of inhibitor of apoptosis proteins in B-cell non-Hodgkin and Hodgkin lymphomas.
    Cancer. 2006;107:1844-51.
    PubMed     Related articles    Abstract available


  57. LEIBOVICI L , Paul M, Cullen M, Bucaneve G, et al
    Antibiotic prophylaxis in neutropenic patients: new evidence, practical decisions.
    Cancer. 2006;107:1743-51.
    PubMed     Related articles    Abstract available


  58. BROWN LM , Howard RA, Travis LB
    The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma.
    Cancer. 2006;.
    PubMed     Related articles   


  59. COLEMAN M , Kostakoglu L
    Early 18F-labeled fluoro-2-deoxy-D-glucose positron emission tomography scanning in the lymphomas: changing the paradigms of treatments?
    Cancer. 2006;107:1425-8.
    PubMed     Related articles    Abstract available


    August 2006
  60. TSIMBERIDOU AM , O'brien S, Kantarjian HM, Koller C, et al
    Hodgkin transformation of chronic lymphocytic leukemia: the M. D. Anderson Cancer Center experience.
    Cancer. 2006;.
    PubMed     Related articles    Abstract available


Thank you for your interest in scientific medicine.


Amedeo is a Bernd Sebastian Kamps website.

   Design: